Delivery Order SPE2DB22D6029-SPE2DB25FLTPD

Award Date 1/2/25
Potential Completion Date 1/24/25
Potential Value $1.1K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $3,714.90 firm fixed-price delivery order is for the supply of ZILRETTA 32 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of February 7, 2025 and does not have a set-aside designation, indicating open competition. AmerisourceBergen holds a significant $999,999,999 Indefinite...
The Defense Logistics Agency (DLA) awarded a firm fixed price delivery order to AmerisourceBergen Drug Corp, a subsidiary of AmerisourceBergen Corporation, to provide ZILRETTA 32 MG VIALS. The order, valued at $2,804.56, has a completion date of March 26, 2024. AmerisourceBergen Drug Corp, a for-profit organization, is the prime contractor on this delivery order, which does not have a set-aside designation. The order is part of a larger indefinite delivery contract (IDC) with a potential value...
The Defense Logistics Agency (DLA) Troop Support Medical has awarded a firm fixed price delivery order contract to Amerisourcebergen Drug Corp, a subsidiary of the global pharmaceutical company Amerisourcebergen Corporation. The $1,051.71 contract is for the provision of ZILRETTA 32 MG VIALS, with a performance period through March 22, 2024. This order is placed under Amerisourcebergen Drug Corp's existing indefinite delivery contract (IDC) with DLA, valued at up to $999,999,999.00 through...
This is a federal contract award to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, by the Defense Logistics Agency (DLA). The $1,857.45 firm fixed-price delivery order is for the supply of ZILRETTA 32 MG VIALS, a pharmaceutical product. The contract has an ultimate completion date of March 3, 2025. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at $999,999,999 and running...
This is a delivery order awarded to Amerisourcebergen Drug Corp's Corporate Office Division by the Defense Logistics Agency (DLA), a defense agency, for the supply of ZILRETTA 32 MG VIALS. The award, valued at $1,752.85, is a firm fixed-price contract with a completion date of May 29, 2024. This delivery order falls under a larger Indefinite Delivery Contract (IDC) that Amerisourcebergen holds with the DLA Troop Support Medical, valued at up to $999,999,999.00 through December 31, 2025. The...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distribution and healthcare solutions provider. The contract is for the supply of ZILRETTA 32 MG VIALS, a specialty medication, valued at $1,485.96. The contract has a period of performance through February 27, 2025 and is a firm fixed-price delivery order. The contract is not designated with a set-aside requirement, indicating open competition. AmerisourceBergen...
The U.S. Defense Logistics Agency (DLA) Troop Support Medical awarded a firm fixed price delivery order contract to AmerisourceBergen Drug Corporation, a subsidiary of AmerisourceBergen Corporation, to supply 4,564,041,099 units of the pharmaceutical product ZILRETTA 32 MG VIALS. The $3,505.70 contract has an ultimate completion date of April 11, 2024. AmerisourceBergen Drug Corporation is the prime contractor for this award, which is not associated with any set-aside designations. Additionally,...
This is a firm fixed price delivery order awarded by the Defense Logistics Agency (DLA) Troop Support Medical to Amerisourcebergen Drug Corp, a subsidiary of Amerisourcebergen Corporation, for the provision of ZILRETTA 32 MG VIALS. The delivery order, valued at $1,051.71, is part of a larger indefinite delivery contract (IDC) held by Amerisourcebergen Drug Corp with DLA, which has a potential value of $999,999,999.00 and a performance period through December 31, 2025. This IDC serves as the...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) Troop Support Medical to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, to supply ZILRETTA 32 MG VIALS. The contract has a ceiling value of $1,402.28 and will run through September 10, 2024. It is a firm-fixed-price contract with no set-aside designation. AmerisourceBergen holds several Indefinite Delivery Contracts (IDCs) with various federal agencies, including a $999,999,999 IDC with DLA Troop...
This is a delivery order contract awarded by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor, for the supply of 32 mg vials of ZILRETTA, a medication used for pain management. The contract has a firm fixed price of $1,485.96 and a period of performance through February 18, 2025. The contract is not designated as a set-aside. AmerisourceBergen holds a significant Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued...
  • SPE2DB22D6029
    Indefinite Delivery Contract
  • SPE2DB22D6029-SPE2DB25FLTPD
    Delivery Order

The Defense Logistics Agency (DLA) awarded a $1,114.47 firm-fixed-price delivery order contract to AmerisourceBergen Drug Corp for the supply of 32 mg vials of ZILRETTA, a pharmaceutical product. The contract has a completion date of January 24, 2025 and was awarded on January 2, 2025. This delivery order is part of a larger Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. The IDC provides a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract award did not have a set-aside designation, indicating open competition.

Generated 4/6/25, 12:46 AM